- PR Newswire•5 months ago
CHICAGO, May 10, 2016 /PRNewswire/ -- Positron Corporation (OTC Markets: POSCE) (the "Company"), a nuclear medicine healthcare company, announced today that the Company entered into a settlement agreement for structured dismissal. If confirmed, the settlement will allow the Company to avoid entering a bankruptcy proceeding. On May 2, 2016, the Company and its petitioning creditors filed a Joint Motion to Approve Agreed Structured Dismissal Pursuant to Bankruptcy Rule 9019. Any shareholders desiring to object to the terms of the Structured Dismissal Agreement have until May 26, 2016, to file a written objection with the Clerk of the United States Bankruptcy Court, 1205 Texas Avenue, Lubbock, Texas 79401. The petitioning creditors filed an involuntary chapter 11 bankruptcy petition against the Company in the U.S. Bankruptcy Court for the Northern District of Texas, Lubbock Division, in a case pending under Case No. 15-502015-rlj, and styled: In re: Positron Corporation.
We're sorry this is all we were able to find about this topic.
Positron Corporation (POSC)
Other OTC - Other OTC Delayed Price. Currency in USD
At close: 8:10 PM EDT
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.32|
|Avg Vol (3m)||305|
|Dividend & Yield||N/A (N/A)|